investing for beginners


Related AMZN The Market In 5 Minutes: Thursday, March 10, 2016 The Best ETF Since The Start Of The Bull Market Is… Box Benefits From IBM Deals; More To Come With Microsoft? (Investor’s Business Daily)

In a pair of new reports, Wall Street analysts weigh in on two important recent developments for Amazon.com, Inc. (NASDAQ: AMZN).

First, Pacific Crest analyst Edward Yruma discussed Amazon’s new fashion show
Style Code Live.” According to Yruma, the new show is an innovative approach to apparel marketing.

investing for beginners: Citrix Systems Inc.(CTXS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Wynn Resortsgained 4.8% to $104.30 today, while the S&P 500 finished little changed at2,373.47. At 2:45, Wynn was easily the top performing stock in the S&P 500, only to be surpassed by Citrix’s (CTXS) late day surge.

  • [By Jim Robertson]

    At the beginning of the month, LogMeIn announced the completion of its merger with Citrix Systems, Inc (NASDAQ: CTXS) GetGo, Inc subsidiary.

    In late October, LogMeIn reported 22% third quarter revenue growth to $85.1 million and GAAP net loss was $0.7 million compared to a GAAP net income of $5.6 million. LogMeIn will report its fourth quarter and fiscal year 2016 financial results for the period ended December 31, 2016 following the close of market on February 28.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Citrix Systems, Inc. (NASDAQ: CTXS) which jumped 6.8% to $84.93. The stocks 52-week range is $59.72 to $87.99. Volume was 5.19 million which is well above the daily average of around 2.09 million shares.

  • [By Ben Levisohn]

    Citrix Systems (CTXS)soared nearly to the top of the S&P 500 today afterreports it had hired Goldman Sachs (GS) to pursue a sale of the company.

    S. MARTIN/AFP/Getty Images

    Citrix Systemsgained 6.8% to $84.93 today, while the S&P 500 finished little changed at 2,373.47.

    Business Insider’s Matt Weinbergerhas the details:

    Citrix, the $13 billion tech company best known for software like GoToMeeting, is working with Goldman Sachs to negotiate a possible sale, reports Bloomberg, citing anonymous sources.


    This isn’t the first time that Citrix has shopped itself around: in late 2015, and under pressure from activist shareholder Elliott Management, Citrix was said to have unsuccessfully tried to find a buyer.

    Citrix Systems market cap rose t0 $13.3 billion today from $12.4 billion on Friday. It reported net income of $536 million on sales of $3.4 billion in 2016.

investing for beginners: Flextronics International Ltd.(FLEX)

Advisors’ Opinion:

  • [By Amber Hestla, Michael J. Carr]

    Among its suppliers is Flextronics International (Nasdaq: FLEX), which offers a variety of engineering services and provides supply chain management. Other Flextronics customers include Hewlett-Packard (NYSE: HPQ), LG and Google's (Nasdaq: GOOG) Motorola Mobility. 

  • [By Peter Graham]

    A long term performance chart shows shares of mid cap Jabil Circuit and small capCelestica Inc (NYSE: CLS) heading back into positive territory while shares of mid cap Flextronics International Ltd (NASDAQ: FLEX) and small capSanmina Corp (NASDAQ: SANM) (a previous SmallCap Network Elite Opportunitynewslettersuggestion as the next breakout stock) have been much better performers as they took off early last year:

  • [By Peter Graham]

    Mid cap electronic manufacturing services (EMS) stock Flextronics International Ltd (NASDAQ: FLEX) reported Q1 2017 earnings after the market closed on Thursday with results missing Wall Street expectations and shares falling in afterhours/premarket trading. Net sales grew 2% to $6.0 billion and GAAP net income was approximately $125 millionversus net income of $106 million. The CEO commented:

  • [By Peter Graham]

    A long term performance chart shows Sanmina Corp along with potential peersCelestica Inc (NYSE: CLS), Jabil Circuit, Inc (NYSE: JBL) and Flextronics International Ltd (NASDAQ: FLEX)all having similar looking charts; but SANM has been the outperformer:

investing for beginners: Enerplus Corporation(ERF)


Advisors’ Opinion:

  • [By Money Morning News Team]

    Enerplus Corp. (NYSE: ERF) is a $2.1 billion oil company based in Calgary and trades on both the NYSE and Toronto Stock Exchange. ERF primarily produces crude oil in the Bakken fields in North Dakota and Western Canada.

investing for beginners: Cleveland BioLabs, Inc.(CBLI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell by 0.98 percent. Meanwhile, top losers in the sector included Cleveland BioLabs, Inc. (NASDAQ: CBLI), down 25 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI), down 8 percent.

  • [By Alex McGuire]

    You see, penny stocks are attractive because they can offer double-digit or even triple-digit returns in a very short time. For example, Cleveland BioLabs Inc. (Nasdaq: CBLI) skyrocketed from $1.56 at the Thursday, April 13, close to $5.10 on Wednesday, April 19. That’s a stunning 227% return in just three sessions (the markets were closed that Friday).

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

Leave a Reply

Your email address will not be published.